Advertisement

Intrathecal baclofen therapy; patient selection & team approach

  • Akinobu Nemoto
Conference paper
Part of the Acta Neurochirurgica Supplements book series (NEUROCHIRURGICA, volume 87)

Summary

Intrathecal baclofen therapy (ITB therapy) is useful for severe spasticity. However, the Ministry of health, labour and welfare has not allowed the therapy in Japan. A clinical trial of intrathecal baclofen therapy is currently under way. In this paper the situation in Japan with regard to ITB therapy is described and information for physicians in Japan given from our experience. Team approach is important for ITB therapy. Special attention should be paid to patient selection.

Keyword

Intrathecal baclofen therapy clinical trial team approach 

References

  1. 1.
    Albright AL, Barron WB, Fasick MP, Polinko P, Janosky J (1993) Continuous intrathecal baclofen infusion for spasticity of cerebral origin. JAMA 24; 270: 2475–2477CrossRefGoogle Scholar
  2. 2.
    Albright AL (1996) Intrathecal baclofen in cerebral palsy movement disorders. J Child Neurol 11: S29–35PubMedCrossRefGoogle Scholar
  3. 3.
    Albright AL, Barry MJ, Shafton DH, Ferson SS (2001) Intrathecal baclofen for generalized dystonia. Dev Med Child Neurol 43: 652–657PubMedCrossRefGoogle Scholar
  4. 4.
    Coffey RJ, Edgar TS, Francisco GE, Graziani V, Meythaler JM, Ridgely PM, Sadiq SA, Turner MS (2002) Abrupt withdrawal from intrathecal baclofen: recognition and management of a potentially life-threatening syndrome. Arch Phys Med Rehabil 83: 735–741PubMedCrossRefGoogle Scholar
  5. 5.
    Gormley ME Jr (1999) Management of spasticity in children: part 2: oral medications and intrathecal baclofen. J Head Trauma Rehabil 14: 207–209PubMedCrossRefGoogle Scholar
  6. 6.
    Meythaler JM, Guin-Renfroe S, Law C, Grabb P, Hadley MN (2001) Continuously infused intrathecal baclofen over 12 months for spastic hypertonia in adolescents and adults with cerebral palsy. Arch Phys Med Rehabil 82: 155–161PubMedCrossRefGoogle Scholar
  7. 7.
    Meythaler JM, Guin-Renfroe S, Brunner RC, Hadley MN (2001) Intrathecal baclofen for spastic hypertonia from stroke. Stroke 32: 2099–2109PubMedCrossRefGoogle Scholar
  8. 8.
    Nance P, Meythaler J (1999) Intrathecal drug therapy. Phys Med Rehabil Clin N Am 10: 385–401PubMedGoogle Scholar
  9. 9.
    Penn RD (1992) Intrathecal baclofen for spasticity of spinal origin: seven years of experience. J Neurosurg 77: 236–240PubMedCrossRefGoogle Scholar
  10. 10.
    Taira T, Kawamura H, Tanikawa T, Kawabatake H, Iseki H, Ueda A, Takakura K (1995) New approach to the control of central deafferentation pain — spinal intrathecal baclofen. Acta Neurochir (Wien) [Suppl] 64: 136–138CrossRefGoogle Scholar

Copyright information

© Springer-Verlag Wien 2003

Authors and Affiliations

  1. 1.Department of medical informaticsYokohama City University HospitalJapan

Personalised recommendations